|
Naltrexone Clinical Trials
4 actively recruiting trials across 4 locations
▲ +1 trial since August 2026
Also known as: LDN
Pipeline
Phase 1: 1Phase 2: 2Phase 2/3: 1
Top Sponsors
- University of Arkansas1
- Sarah Weiss1
- Dartmouth-Hitchcock Medical Center1
- AgelessRx1
Indications
- Cancer2
- Geroscience1
- Longevity1
- GLP - 11
- Painful Diabetic Neuropathy1
Little Rock, Arkansas1 trial
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
University of Arkansas for Medical Sciences
Phase 2
Chicago, Illinois1 trial
Lebanon, New Hampshire1 trial
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
Dartmouth-Hitchcock Medical Center
Phase 2
New Brunswick, New Jersey1 trial
Naltrexone and Propranolol Combined With Immunotherapy
Rutgers Cancer Institute of New Jersey
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.